Chemo Drugs Flashcards
Antimetabolites
Drugs: Methotrexate, Fluorouracil
Methotrexate
An antimetabolite (Compete with purine or pyrimidine analogs by getting incorporated into RNA/DNA inhibiting synthesis, targets S phase of cell cycle)
Folate antagonist
Indications: ALL, breast ca, head and neck ca, non-Hodgkin’s lymphoma, osteosarcoma
Adverse Effects: Acute N,V, mucositis,
Delayed: myelosuppression, nephrotoxicity, hepatotoxicity, photosensitivity, pulmonary toxicity
fluorouracil (pyrimidine analog)
Indications: Breast, colon and gastric CA
Adverse Effects - Acute: N/V/D
Delayed: Stomatitis, GI ulcer, hand-foot syndrome, cardiotoxicity, photosensitivity, myelosuppresion
topoisomerase inhibitors
Etoposide, Irinotecan
MOA: Binds topo I and stabilizes cleavable complex, so relegation of cleaved DNA strand cannot occur. Leads to DNA strand break. Targets S phase of cell cycle.
Indications: small cell lung ca, NHL
Etoposide
topoisomerase inhibitors
Indications: small cell lung ca, NHL
Adverse Effects: Acute: N/V/D, hypersensitivity, fever, hypotension Delayed: myelosuppression, alopecia, fatigue
inflamed mucous membranes, secondary malignancies, hepatoxicity (from lecture)
irinotecan
topoisomerase inhibitors
Indications: small cell lung ca, NHL
Adverse Effects: Acute:N/V/D cholinergic syndrome,
Delayed: myelosuppression, alopecia, asthenia
anthracyclines (topoisomerease II inhibitor)
doxorubicin
MOA: Binds to topo II and causes DNA strand breaks, targets S/G2 phase of cell cycle
Indications: breast ca, metastatic solid tumors, leukemia, lymphoma
doxorubicin
Anthracycline (topoisomerease II inhibitor)
MOA: Binds to topo II and causes DNA strand breaks, targets S/G2 phase of cell cycle
Indications: breast ca, metastatic solid tumors, leukemia, lymphoma
Adverse Effects: cardiotoxicity, extravasation potential, secondary malignancies, hepatic function impairement, myelosupression
antimicrotubules - taxanes
MOA: Promotes formation of microtubules and prevents disassembly of microtubules, targets G2/M phase
Drug: Paclitaxel
Indications: ALL, CNS tumors, Hodgkin lymphoma, NHL
Adverse Effects: Acute: N/V/D, hypersensitivity
Delayed: peripheral neuropathy, alopecia, mucositis, arthralgias
vinca alkyloids
MOA: Binds to tubulin and inhibits microtubule assembly, targets M phase
Drug: Vincristine
Indications: ALL, CNS tumors, Hodgkin lymphoma, NHL
Paclitaxel
Class: antimicrotubules - taxanes
MOA: Promotes formation of microtubules and prevents disassembly of microtubules, targets G2/M phase
Indications: ALL, CNS tumors, Hodgkin lymphoma, NHL
Adverse Effects: Acute: N/V/D, hypersensitivity
Delayed: peripheral neuropathy, alopecia, mucositis, arthralgias
Vincristine
Class: vinca alkyloids
MOA: Binds to tubulin and inhibits microtubule assembly, targets M phase
Indications: ALL, CNS tumors, Hodgkin lymphoma, NHL
Adverse Effects: Acute: constipation, nausea
Delayed: fatigue neurotoxicity, cranial nerve disorder
alkylating agents
Drugs: cyclophosphamide, cisplatin
Indications: breast ca, lymphomas, leukemias (cyclophosphamide), solid tumors (cisplatin)
cyclophosphamide
Class: alkylating agents
Indications: breast ca, lymphomas, leukemias
Adverse Effects: Acute: N/V
Delayed: hemorrhagic cystitis, cardiotoxicity, alopecia, myelosuppression
cisplatin
Class: alkylating agents
Indication: solid tumors
Adverse Effects: Acute: N/V
Delayed: renal toxicity, ototoxicity,neurotoxicity, myelosuppression, electrolyte disturbances